Parametersa | With FSD (n = 85) | Without FSD (n = 120) | p-valueb |
---|---|---|---|
Age (years) | 33.00 (31.00–35.00) | 28.00 (22.00–30.00) | < 0.001 |
BMI (kg/m2) | 23.77 (21.92–27.34) | 22.49 (19.85–24.15) | 0.020 |
TC (mg %) | 167.00 (140.00–200.00) | 161.50 (127.09–192.50) | 0.362 |
HDLc (mg %) | 55.50 (50.10–62.00) | 54.75 (48.90–60.00) | 0.550 |
LDLc (mg %) | 94.80 (58.00–120.80) | 84.30 (57.45–110.00) | 0.275 |
TG (mg %) | 97.00 (72.00–148.00) | 100.00 (71.50–143.50) | 0.824 |
DM duration (years) | 26.00 (25.00–31.00) | 20.00 (9.00–25.50) | 0.005 |
Thyroid disease duration (years) | 15.00 (14.00–18.00) | 14.00 (11.00–16.00) | 0.431 |
TSH (μ/ml) | 7.00 (6.00–13.38) | 1.88 (1.11–3.08) | < 0.001 |
FT4 (pmol/l) | 7.90 (1.20–12.80) | 12.50 (10.95–14.55) | < 0.001 |
ANTITPO AB (UI/ml) | 360.00 (13.15–618.00) | 319.00 (13.15–618.00) | 0.552 |
ANTITG AB (UI/ml) | 90.00 (32.00–816.00) | 237.00 (39.45–923.45) | 0.313 |
Fasting glycemia (mg %) | 162.00 (127.00–244.00) | 160.00 (120.00–200.00) | 0.409 |
Postprandial glycemia (mg %) | 147.42 (119.00–198.90) | 141.11 (102.00–172.00) | 0.408 |
HbA1c (%) | 9.20 (7.95–13.55) | 8.75 (7.40–11.15) | 0.149 |
Diabetes microvascular complications | |||
Retinopathy | 15 (17.6%) | 9 (7.5%) | 0.026 |
Nephropathy | 1 (1.17%) | 1 (0.83%) | 0.978 |
Diabetic polyneuropathy | 18 (21.2%) | 12 (10%) | 0.026 |
Diabetes macrovascular complications | 11 (12.94%) | 5 (4.16%) | 0.086 |
Hypertension | 18 (21.17%) | 10 (8.33%) | 0.030 |
Chronic cardiac ischemic disease | 10 (11.76%) | 4 (3.33%) | 0.089 |
Hypertension treatment (beta-blockers) | 11 (12.94%) | 5 (9.4%) | 0.086 |
Use of insulin pump | 21 (24.7%) | 5 (4.2%) | < 0.001 |
Goiter | 21 (24.7%) | 10 (8.33%) | 0.018 |
Depression | 57 (67.05%) | 5 (4.2%) | < 0.001 |